Publications by authors named "Vasyl M Voronych"
Article Synopsis
- The study aims to compare the effects of three treatments—tofacitinib, adalimumab, and budesonide—on patients with moderate ulcerative colitis (UC) accompanied by joint issues.
- 100 moderately severe UC patients were divided into three groups: one received tofacitinib, another adalimumab, and the last budesonide, with respective dosages outlined.
- Results showed that both tofacitinib and adalimumab significantly reduced leukocyte and CRP levels and increased hemoglobin levels more effectively than budesonide in treating moderate UC with joint problems.
